DK426185A - Nucleosid- og purinderivater - Google Patents

Nucleosid- og purinderivater Download PDF

Info

Publication number
DK426185A
DK426185A DK426185A DK426185A DK426185A DK 426185 A DK426185 A DK 426185A DK 426185 A DK426185 A DK 426185A DK 426185 A DK426185 A DK 426185A DK 426185 A DK426185 A DK 426185A
Authority
DK
Denmark
Prior art keywords
sub
purine derivatives
nucleoside
hydrogen
amino
Prior art date
Application number
DK426185A
Other languages
English (en)
Other versions
DK167318B1 (da
DK426185D0 (da
Inventor
Silvano Casadio
Duccio Favara
Amedeo Omodei-Sale
Ezio Panto
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of DK426185D0 publication Critical patent/DK426185D0/da
Publication of DK426185A publication Critical patent/DK426185A/da
Application granted granted Critical
Publication of DK167318B1 publication Critical patent/DK167318B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK426185A 1984-09-20 1985-09-19 8-substituerede puriner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne DK167318B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2273984 1984-09-20
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Publications (3)

Publication Number Publication Date
DK426185D0 DK426185D0 (da) 1985-09-19
DK426185A true DK426185A (da) 1986-03-21
DK167318B1 DK167318B1 (da) 1993-10-11

Family

ID=11199882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK426185A DK167318B1 (da) 1984-09-20 1985-09-19 8-substituerede puriner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne

Country Status (14)

Country Link
US (1) US4774325A (da)
EP (1) EP0175325B1 (da)
JP (1) JPS61112077A (da)
AT (1) ATE41430T1 (da)
AU (1) AU591462B2 (da)
CA (1) CA1268175A (da)
DE (1) DE3568783D1 (da)
DK (1) DK167318B1 (da)
ES (1) ES8701773A1 (da)
GR (1) GR852261B (da)
IT (1) IT1196261B (da)
NZ (1) NZ213550A (da)
PT (1) PT81045B (da)
ZA (1) ZA857075B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
AU6449394A (en) * 1993-03-30 1994-10-24 Sterling Winthrop Inc. Acyclic nucleoside analogs and oligonucleotide sequences containing them
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
AU2002252179A1 (en) * 2001-03-01 2002-09-19 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
EP2336133A1 (en) * 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
JP3929949B2 (ja) * 2003-08-08 2007-06-13 独立行政法人科学技術振興機構 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法
BRPI0414533A (pt) * 2003-09-18 2006-11-07 Conforma Therapeutics Corp composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
CA2602257A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
US20070105874A1 (en) * 2005-09-23 2007-05-10 Conforma Therapeutics Corporation Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 Inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE111312C (da) * 1897-12-16
US2819260A (en) * 1953-06-04 1958-01-07 Petrolite Corp Process for preparing oxyalkylated derivatives
US3391196A (en) * 1965-08-16 1968-07-02 Wyandotte Chemicals Corp High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols
US3712885A (en) * 1968-09-10 1973-01-23 G Weimann Purine-ribofuranoside-3',5'-cyclophosphates and process for their preparation
JPS5133799B2 (da) * 1973-06-14 1976-09-21
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
DE2631046A1 (de) * 1975-07-15 1977-01-20 Snam Progetti Adeninderivate und verfahren zu deren herstellung
SU883056A1 (ru) * 1980-03-26 1981-11-23 Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0045544B1 (en) * 1980-08-06 1985-03-20 Shell Internationale Researchmaatschappij B.V. Process for the manufacture of polyether polyols and their use for preparing polyurethanes
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体

Also Published As

Publication number Publication date
ES547856A0 (es) 1987-01-01
IT8422739A0 (it) 1984-09-20
EP0175325A3 (en) 1987-02-04
ATE41430T1 (de) 1989-04-15
ZA857075B (en) 1986-06-25
EP0175325A2 (en) 1986-03-26
JPS61112077A (ja) 1986-05-30
PT81045A (en) 1985-09-01
DK167318B1 (da) 1993-10-11
JPH0569109B2 (da) 1993-09-30
DE3568783D1 (en) 1989-04-20
DK426185D0 (da) 1985-09-19
US4774325A (en) 1988-09-27
AU4767285A (en) 1986-03-27
AU591462B2 (en) 1989-12-07
CA1268175A (en) 1990-04-24
EP0175325B1 (en) 1989-03-15
IT1196261B (it) 1988-11-16
IT8422739A1 (it) 1986-03-20
ES8701773A1 (es) 1987-01-01
NZ213550A (en) 1989-06-28
PT81045B (pt) 1987-09-18
GR852261B (da) 1986-01-17

Similar Documents

Publication Publication Date Title
DK426185A (da) Nucleosid- og purinderivater
UA6343A1 (uk) Спосіб одержання похідних 2-оксоінділ-1-карбоксаміда
FI850850L (fi) Antipsykotiska 1-fluorfenylbutyl-4-( 2-pyrimidinyl) piperazinderivat.
JPS57144298A (en) 7-beta-d-arabinofuranosyl-7h- pyrrolo(2,3-d)pyrimidine compound and manufacture
ATE53588T1 (de) Herstellung von cytosin-nukleosiden.
ES2091322T3 (es) Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa.
EP0254902A3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
ES545575A0 (es) Un procedimiento para la preparacion de tiazolidinas
DK333785D0 (da) Mevalonolactonderivater
ATE31295T1 (de) Benzoylharnstoffderivate.
ATE54307T1 (de) Pantothenolderivate.
ES2001676A6 (es) Procedimiento para la preparacion de derivados propionamidinos
ATE65986T1 (de) Propanolabkoemmlinge.
AU557360B2 (en) Substituted ethenyl derivatives of 1h-pyrazolo (1,5-alpha) pyrimidine
ES8404358A1 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
JPS53124293A (en) Novel adenosine derivatives
SU892892A1 (ru) 3-Дицианметилпиримидо-[4,5-е][1,2,4]-триазин-6,8-дион гидрат, обладающий противовоспалительной активностью
IT1222863B (it) Derivati naturali ad attivita' biologica
IT1222864B (it) Preparati cosmetici liposomiali
SU1251528A1 (ru) Пленка - подложка для культивирования животных клеток
GR80538B (en) Use of hydrogen as an energy source
JPS5432469A (en) Novel imidazoline riboside derivatives and their preparation

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed